KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Goodwill: 2009-2025

Historic Goodwill for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to $15.9 billion.

  • Teva Pharmaceutical Industries' Goodwill fell 1.11% to $15.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $15.9 billion, marking a year-over-year decrease of 1.11%. This contributed to the annual value of $15.1 billion for FY2024, which is 11.82% down from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Goodwill stood at $15.9 billion for Q3 2025, which was down 0.03% from $15.9 billion recorded in Q2 2025.
  • Teva Pharmaceutical Industries' 5-year Goodwill high stood at $20.4 billion for Q2 2021, and its period low was $479.0 million during Q2 2022.
  • For the 3-year period, Teva Pharmaceutical Industries' Goodwill averaged around $16.5 billion, with its median value being $16.5 billion (2024).
  • Its Goodwill has fluctuated over the past 5 years, first tumbled by 97.65% in 2022, then soared by 3,473.70% in 2023.
  • Teva Pharmaceutical Industries' Goodwill (Quarterly) stood at $17.6 billion in 2021, then fell by 2.59% to $17.2 billion in 2022, then remained steady at $17.2 billion in 2023, then decreased by 11.82% to $15.1 billion in 2024, then fell by 1.11% to $15.9 billion in 2025.
  • Its Goodwill was $15.9 billion in Q3 2025, compared to $15.9 billion in Q2 2025 and $15.5 billion in Q1 2025.